» Articles » PMID: 3711278

Persistence of Chlamydial Antibodies After Pelvic Inflammatory Disease

Overview
Specialty Microbiology
Date 1986 May 1
PMID 3711278
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

The persistence of chlamydial immunoglobulin G (IgG) antibodies and long-term sequelae of pelvic inflammatory disease (PID) were studied in 70 women who had been treated for PID 3 to 6 years previously. Fifty-one women had had PID associated with Chlamydia trachomatis infection (Chlamydia group), and 19 women had had PID not associated with C. trachomatis (non-Chlamydia group). Chlamydial IgG antibodies, as determined by the indirect immunofluorescence test with inclusions of C. trachomatis L2 as antigens, persisted at stable levels in 43% of the women for up to 6 years; 43% of the women showed a decrease in IgG titer, and 13% showed an increase. IgA antibody levels in serum correlated with IgG antibody levels in serum and with the presence of cervical IgA antibodies. Both serum antibodies and cervical IgA antibodies were more often found in the Chlamydia group. Forty-two percent of the women were infertile. Every fifth subsequent pregnancy was ectopic. The presence of cervical IgA antibodies might protect the women from tubal damage.

Citing Articles

Seroepidemiology of Infection in the General Population of Northern China: The Jidong Community Cohort Study.

Shui J, Xie D, Zhao J, Ao C, Lin H, Liang Y Front Microbiol. 2021; 12:729016.

PMID: 34650533 PMC: 8507574. DOI: 10.3389/fmicb.2021.729016.


Chlamydia trachomatis, Chlamydial Heat Shock Protein 60 and Anti-Chlamydial Antibodies in Women with Epithelial Ovarian Tumors.

Jonsson S, Oda H, Lundin E, Olsson J, Idahl A Transl Oncol. 2018; 11(2):546-551.

PMID: 29524832 PMC: 5884191. DOI: 10.1016/j.tranon.2018.02.008.


The potential role of infectious agents and pelvic inflammatory disease in ovarian carcinogenesis.

Ingerslev K, Hogdall E, Schnack T, Skovrider-Ruminski W, Hogdall C, Blaakaer J Infect Agent Cancer. 2017; 12:25.

PMID: 28529540 PMC: 5437405. DOI: 10.1186/s13027-017-0134-9.


Validity of self-reported history of Chlamydia trachomatis infection.

Frisse A, Marrazzo J, Tutlam N, Schreiber C, Teal S, Turok D Am J Obstet Gynecol. 2016; 216(4):393.e1-393.e7.

PMID: 27988270 PMC: 6251056. DOI: 10.1016/j.ajog.2016.12.005.


Antibody to Chlamydia trachomatis proteins, TroA and HtrA, as a biomarker for Chlamydia trachomatis infection.

Hokynar K, Korhonen S, Norja P, Paavonen J, Puolakkainen M Eur J Clin Microbiol Infect Dis. 2016; 36(1):49-56.

PMID: 27638011 DOI: 10.1007/s10096-016-2769-7.


References
1.
Westrom L . Effect of acute pelvic inflammatory disease on fertility. Am J Obstet Gynecol. 1975; 121(5):707-13. DOI: 10.1016/0002-9378(75)90477-9. View

2.
DEKKING F . Epidemiology of ornithosis and psittacosis. Arch Gesamte Virusforsch. 1963; 13:316-22. DOI: 10.1007/BF01243858. View

3.
Schachter J . Chlamydial infections (third of three parts). N Engl J Med. 1978; 298(10):540-9. DOI: 10.1056/NEJM197803092981005. View

4.
Paavonen J, Saikku P, Vesterinen E, Meyer B, Vartiainen E, Saksela E . Genital chlamydial infections in patients attending a gynaecological outpatient clinic. Br J Vener Dis. 1978; 54(4):257-61. PMC: 1045514. DOI: 10.1136/sti.54.4.257. View

5.
Saikku P, Paavonen J . Single-antigen immunofluorescence test for chlamydial antibodies. J Clin Microbiol. 1978; 8(2):119-22. PMC: 275162. DOI: 10.1128/jcm.8.2.119-122.1978. View